STAT Wunderkinds: 5 years of progress
As the Wunderkinds program celebrates its fifth anniversary of honoring the brightest early-career researchers in…
Author: STAT
FDA approves first drug for genetic cause of dwarfism
The Food and Drug Administration approved the first treatment for the most common cause of…
Democrats’ major drug pricing reforms clear a hurdle in the House
WASHINGTON — House Democrats Friday broke a monthslong logjam and advanced prescription drug pricing reform…
STAT+: Pharmalittle: FDA expands emergency use for Pfizer and Moderna Covid boosters; Biden move to lower drug prices would save U.S. $160 billion
And so, another working week will soon draw to a close. Not a moment too…
FDA expands emergency authorization for Covid-19 booster shots to all adults
The Food and Drug Administration expanded the emergency use authorization for the Pfizer and Moderna…
STAT+: Watch: Experts challenge Eli Lilly exec on effectiveness of Alzheimer’s drug
Months after the Food and Drug Administration approved Biogen’s Alzheimer’s drug Aduhelm, Eli Lilly hopes…
Opinion: Health plans, insurers need to make addressing racial inequities in health care part of their core work
Health care companies and organizations across the country are grappling with health inequities, spurred by…
Opinion: Lessons from the inverted paradiddle can help telehealth move forward
By day I run a health care company. At night and on weekends I play…
.jpg)
STAT+: Big data is the next frontier for biotech — and they’re scrambling for data scientists
Nikhil Munshi’s lab at the Dana-Farber Cancer Institute has accumulated an overwhelming amount of data…
STAT+: Can local governments convince the courts that opioid makers and wholesalers caused a public nuisance?
Earlier this week, the state of Washington went to trial relying on a controversial legal…
Listen: Biogen’s scientific succession & Michael Osterholm on pandemic Thanksgiving
Are we in for another winter surge? Has Biogen bottomed out? And can Covid-19 pills…
Telehealth for PTSD, SPAC sadness, & FDA clears VR
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: GlaxoSmithKline’s Emma Walmsley predicts a ‘landmark’ 2022 for the company
Next year will be a “landmark” one for GlaxoSmithKline, according to CEO Emma Walmsley —…
STAT+: Proposal to waive intellectual property rights for Covid-19 vaccines and drugs appears unlikely to pass
A controversial proposal for the World Trade Organization to temporarily waive intellectual property rights and…
STAT+: Former DARPA director: Biden’s new science agency should be independent, not an NIH office
WASHINGTON — The former director of DARPA, the Pentagon’s high-stakes research arm, says that for…
STAT+: A lack of access: Pharma is failing to ensure new antibiotics will be available to poor countries, analysis finds
Although the pharmaceutical industry is making modest progress in countering resistance to superbugs, drug companies…
A win for Black maternal health advocates, as Congress moves to set up new VA program
Congress’s action this week is a victory for Black maternal health advocates like Charles Johnson,…
‘Growing a chair is easy’ and other words of wisdom from the audacious George Church
George Church, the larger-than-life Harvard biologist who pioneered both DNA sequencing and gene editing, is…
STAT+: Generate Biomedicines raises $370m and plans to increase workforce sixfold
Cambridge biotech Generate Biomedicines said Thursday it has raised $370 million in venture capital from…
STAT+: Pharmalittle: SEC probes Cassava over Alzheimer’s drug results; Teva takes pharma in a new direction with a bond sale
Rise and shine, everyone. Another busy day is on the way. We can tell because…
STAT+: By selling bonds tied to drug access and climate goals, Teva takes pharma in a new direction
In a first-of-its-kind move by a drug maker, Teva Pharmaceuticals (TEVA) recently sold $5 billion…
STAT+: Gilead licenses cancer drugs from Arcus in potentially lucrative but risky bet on its cancer business
Gilead Sciences said Thursday that it has exercised an option to license four cancer drugs…
Opinion: Why is the CDC missing in action on severe mental illnesses?
In October, the CDC updated its list of medical conditions that contribute to worse outcomes…
Opinion: Vaccine mandates should cover the incarcerated, too, not just prison guards and workers
Federal, state, and local vaccine mandates are being opposed by several high-profile groups, including firefighters,…
Lessons from a Flint water crisis researcher about building trust in science during the pandemic
Siddhartha Roy was only a graduate student in 2015 when he found himself in the…
STAT+: Set to retire, Alnylam’s Maraganore reflects on his successor and his next steps
John Maraganore’s decision to step down as Alnylam Pharmaceuticals’ CEO after almost 20 years came…
STAT+: ‘Late is better than never’: Biden plan to boost U.S. production of Covid vaccines gets mixed reviews
Under pressure to widen global access to Covid-19 vaccines, the Biden administration plans to invest…
Moderate Democrats are still seeking changes to the party’s drug pricing package
WASHINGTON — Rep. Kurt Schrader, the Oregon Democrat who has played an outsized role in…
STAT+: ‘Can’t get much worse:’ What a European rejection of an Alzheimer’s drug would mean for Biogen
In a potentially huge setback for Biogen (BIIB), a European regulatory panel signaled that it…
STAT+: FDA is urged to disqualify a hospital review board and two doctors over clinical trial missteps
The Food and Drug Administration is being urged to disqualify a Minnesota hospital and two…
5 things to know about monkeypox after a new case appeared in U.S.
For the second time this year, the United States has an imported case of monkeypox….
U.S. overdose deaths topped 100,000 in one year, officials say
NEW YORK — An estimated 100,000 Americans died of drug overdoses in one year, a…
Opinion: People in states without Medicaid expansion can’t wait any longer to build back better
Lawmakers are in the midst of deliberations over the Build Back Better Act, a landmark…
STAT+: Pharmalittle: European regulators unlikely to approve Biogen Alzheimer’s drug; U.S. to invest billions to expand Covid vaccine production
Hello, everyone, and welcome to the middle of the week. You made it this far,…
Johnson and Johnson’s new vaccines leader talks Covid-19, pipeline plans, and ‘a golden opportunity’ for clinical trials
There’s a changing of the guard at Janssen, Johnson & Johnson’s vaccines division. In June,…
STAT+: European regulators signal Biogen’s new Alzheimer’s therapy is unlikely to win approval
A panel of European drug reviewers notified Biogen that its Alzheimer’s treatment Aduhelm is unlikely…
Opinion: Listen: A resident physician on the Covid-stoked fire that burned him out
Resident physician Sudhakar Nuti was almost too burnt out to write about burnout. He spent…
Opinion: With 128 Covid vaccines in clinical development, we don’t know if the approved/authorized ones are the best ones
Pfizer/BioNTech. Moderna. Johnson & Johnson. AstraZeneca. These are the marquee names that spring to mind…
GOP opposition to vaccine mandates extends far beyond Covid-19
WASHINGTON — Right-wing politicians’ resistance to vaccine mandates is extending far beyond Covid-19 immunizations, a…
A telehealth effort to treat PTSD and bipolar disorder in rural areas showed ‘huge gains.’ Now comes the hard part
A multiyear effort to pipe big-city mental health providers to rural communities over video accomplished…
STAT+: ‘Where’s my prescription?’: California wants to revoke an OptumRx pharmacy license for prescribing lapses
The California Board of Pharmacy is seeking to revoke or suspend a pharmacy license held…
Nancy Hopkins, pioneering biologist and advocate for gender equity in science, wins STAT Biomedical Innovation Award
Nancy Hopkins, an MIT professor who has made significant strides in molecular biology and a…
Fauci on the next phase of the Covid-19 pandemic and the ‘insanity’ of the threats he faces for pushing masks, vaccines
Anthony Fauci, the country’s top infectious disease expert who himself has become a something of…
Pfizer to file for emergency authorization for its Covid-19 pill
In an anticipated move, Pfizer (PFE) CEO Albert Bourla said the company plans ask the…
STAT+: Pharmalittle: Biogen R&D chief retiring amid controversy over Alzheimer’s drug; Pfizer strikes deal for generic versions of its Covid pill
Top of the morning to you, and a fine one it is. Crystal clear blue…
STAT+: The prices of 7 drugs were hiked without proof of new benefits, costing the U.S. $1.6 billion in 2020
During 2020, drug makers raised prices on seven widely used medicines by substantial amounts without…
STAT+: Like Merck, Pfizer strikes a licensing deal with the Medicines Patent Pool for a Covid-19 pill
Amid considerable anticipation over its Covid-19 pill, Pfizer (PFE) reached a licensing agreement with the…
Opinion: Personalized medicine goes far beyond genetics
Since the Human Genome Project was completed in 2003, most public considerations of personalized medicine…
Opinion: The pandemic didn’t increase suicides. That shouldn’t be a surprise
In the early stages of the Covid-19 pandemic, mental health experts and members of the…
The Catholic hospital system Ascension is running a Wall Street-style private equity fund
WASHINGTON — America’s largest Catholic hospital system, Ascension, has quietly built out a strikingly unusual…